|
BIOKÉ announces exclusive distribution agreement with New England Biolabs in the Benelux
|
Leiden, March 1st 2011 - BIOKÉ, a Cell Signaling Technology (CST) Europe company, announced today that it has entered into an exclusive distribution agreement in the Benelux countries, effective April 1st, 2011, with New England Biolabs.
Read More
|
|
| | |
|
|
Roche and Fluidigm Co-Promotion Agreement
|
Leiden, October 25, 2010 - Roche and Fluidigm Corporation Enter Worldwide Co-Promotion Agreement for 454 Sequencing Systems and Access Array Platform.
Read More
|
|
| | |
|
|
Microfluidic Amplification as a Tool for Massive Parallel Sequencing
|
SOUTH SAN FRANCISO, Calif., January 31, 2012 -This newly released paper demonstrates that using the Access Array System from Fluidigm with the Roche GS FLX saves time and money over Sanger sequencing.
|
|
| | |
|
|
Fluidigm Introduces Fast 192.24 Dynamic Array™ IFC For Genotyping
|
Leiden, May 16th, 2011 – Fluidigm Corporation (NASDAQ:FLDM) today introduced its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour.
Read More
|
|
| | |
|
|
Webinar: Proteomics of Post-translational Modifications
|
Leiden, May 24th, 2011 – In association with Science, Cell Signaling Technology will organize a webinar on post-translational modifications (phosphorylation, acetylation, ubiquitination) on Wednesday June 8, 2011.
Read More
|
|
| | |
|
|
Phusion DNA Polymerases still available from NEB
|
Leiden, May 9th, 2011 - Through NEB’s commitment to research and innovation, the Phusion products will now be manufactured at NEB and these products will also be available through BIOKÉ.
Read More
|
|
| | |
|
|
Fluidigm launches low-cost assays
|
Leiden, May 9th, 2011 – Fluidigm launches low-cost assays for gene expression, SNP genotyping and target-specific primers for Next-Generation Sequencing.
Read More
|
|
| | |
|
|
China's Rujin Hospital uses Fluidigm to Validate New Risk Loci for Graves' Disease
|
South San Francisco, Calif. Oct. 3, 2011 - Fluidigm Corporation announced that China's Rujin Hospital in Shanghai has used the integrated fluidic circuits (IFCs) to help validate two new susceptibility loci for Graves' disease.
Read More
|
|
| | |
|
|
BIOKÉ distributor of SensoQuest Thermocyclers
|
Leiden, February 17, 2012 - BIOKÉ, a Cell Signaling Technology Europe company, announced that it has entered into an exclusive distribution agreement in the Benelux countries, effective March 1st, 2012, with SensoQuest.
Read More
|
|
| | |
|
|
New in NextGENe!
|
State College, February 15, 2012 - 99.8 % Accuracy with Ion PGM™ PE reads and NextGENe software’s Floton™ Merge Tool.
Read More
|
|
| | |
|
|
Fluidigm Introduces Access Array™ Barcode Library for Ion Torrent PGM Sequencer
|
SOUTH SAN FRANCISO, Calif., February 13, 2012 – Fluidigm Corporation announced the availability of the Access Array™ Barcode Library for the Ion Torrent Personal Genome Machine (PGM) sequencer.
Read More
|
|
| | |
|
|
New step wise assembler for MiSeq data
|
State College, February 22, 2012 - SoftGenetics has developed a new “step-wise” assembly technology for MiSeq data in NextGENe version 2.2. The technology enables the software to continue the...
Read More
|
|
| | |
|
|
Reduction in STR Analysis Time with SoftGenetics' ChimerMarker Software
|
State College, March 27, 2012 - This newly released Genome News article cites the use of ChimerMarker and how it increases the quality and speed of pre and post BMT analysis.
Read More
|
|
| | |
|